Literature DB >> 7480199

Emodin pharmacokinetics in rabbits.

J W Liang1, S L Hsiu, P P Wu, P D Chao.   

Abstract

Administration of emodin to rabbits by i.v. bolus resulted in a serum profile which could be well described by a two-compartment model. The AUC of emodin was 518 micrograms.min/ml, clearance was 72.3 ml/min, and elimination half life was 227 min which was much longer than that reported in a previous study. Oral administration of emodin resulted in a very low serum concentration. Protein binding of emodin was investigated by the equilibrium dialysis method. Emodin was found to be highly bound (99.6%) to serum protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480199     DOI: 10.1055/s-2006-958125

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

Review 1.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

2.  Contractile effects and intracellular Ca2+ signalling induced by emodin in circular smooth muscle cells of rat colon.

Authors:  Tao Ma; Qing-Hui Qi; Wen-Xiu Yang; Jian Xu; Zuo-Liang Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Signal pathways involved in emodin-induced contraction of smooth muscle cells from rat colon.

Authors:  Tao Ma; Qing-Hui Qi; Jian Xu; Zuo-Liang Dong; Wen-Xiu Yang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

4.  Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.

Authors:  Kun-Che Chang; Linfeng Li; Theresa M Sanborn; Biehuoy Shieh; Patricia Lenhart; David Ammar; Daniel V LaBarbera; J Mark Petrash
Journal:  J Nat Prod       Date:  2016-05-03       Impact factor: 4.050

5.  Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.

Authors:  Tiechuang Wang; Xiaodong Yin; Yaping Lu; Weiguang Shan; Subin Xiong
Journal:  Int J Nanomedicine       Date:  2012-05-08

Review 6.  Mechanism of Emodin in the Treatment of Rheumatoid Arthritis.

Authors:  Lianying Cheng; Jie Chen; Xiaofeng Rong
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-03       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.